Adverse events3,192

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 3,192

Type	Event	Organ system	Group	Affected	At risk
other	Anemia	Blood and lymphatic system disorders	Initial Period: Tofacitinib 5 Milligram(mg) Twice Daily (BID)	64	1,123
other	Anemia	Blood and lymphatic system disorders	Initial Period: Tofacitinib 10 mg BID	176	3,358
other	Anemia	Blood and lymphatic system disorders	Initial Period: All Tofacitinib	240	4,481
other	Anemia	Blood and lymphatic system disorders	Extension Period: Tofacitinib 5 mg	0	48
other	Diarrhoea	Gastrointestinal disorders	Initial Period: Tofacitinib 5 Milligram(mg) Twice Daily (BID)	72	1,123
other	Diarrhoea	Gastrointestinal disorders	Initial Period: Tofacitinib 10 mg BID	213	3,358
other	Diarrhoea	Gastrointestinal disorders	Initial Period: All Tofacitinib	285	4,481
other	Diarrhoea	Gastrointestinal disorders	Extension Period: Tofacitinib 5 mg	0	48
other	Nausea	Gastrointestinal disorders	Initial Period: Tofacitinib 5 Milligram(mg) Twice Daily (BID)	56	1,123
other	Nausea	Gastrointestinal disorders	Initial Period: Tofacitinib 10 mg BID	175	3,358
other	Nausea	Gastrointestinal disorders	Initial Period: All Tofacitinib	231	4,481
other	Nausea	Gastrointestinal disorders	Extension Period: Tofacitinib 5 mg	0	48
other	Bronchitis	Infections and infestations	Initial Period: Tofacitinib 5 Milligram(mg) Twice Daily (BID)	141	1,123
other	Bronchitis	Infections and infestations	Initial Period: Tofacitinib 10 mg BID	430	3,358
other	Bronchitis	Infections and infestations	Initial Period: All Tofacitinib	571	4,481
other	Bronchitis	Infections and infestations	Extension Period: Tofacitinib 5 mg	0	48
other	Herpes zoster	Infections and infestations	Initial Period: Tofacitinib 5 Milligram(mg) Twice Daily (BID)	117	1,123
other	Herpes zoster	Infections and infestations	Initial Period: Tofacitinib 10 mg BID	373	3,358
other	Herpes zoster	Infections and infestations	Initial Period: All Tofacitinib	490	4,481
other	Herpes zoster	Infections and infestations	Extension Period: Tofacitinib 5 mg	0	48

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00413699/events

API reference For AI assistants

Adverse events3,192

Sources 3

Read this list from software.